Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Mesenchymal Stem Cells Escalated Application in Amyotrophic Lateral Sclerosis Patients: Study Design of a Phase I Trial

NCT02987413 is registered in ClinicalTrials.gov with Hospital e Maternidade Dr. Christóvão da Gama as lead sponsor.

NCT NCT02987413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02987413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Mesenchymal Stem Cells Escalated Application in Amyotrophic Lateral Sclerosis Patients: Study Design of a Phase I Trial
Lead sponsor
Hospital e Maternidade Dr. Christóvão da Gama
Phase
Phase 1
Overall status
Completed
Start date
April 28, 2015
Completion date
April 5, 2017
Enrollment
3 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

motor neuron disease